Wilson Sonsini Goodrich & Rosati advised Saranas on the deal, while Latham & Watkins represented Baird Capital. Houston, Texas-based Saranas announced a $12.8 million Series B...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins advised EnCap Investments L.P. on the deal. EnCap Investments L.P., a leading provider of growth capital to the independent sector of the U.S....
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP and Wilson Sonsini Goodrich & Rosati represented Erasca in the transaction. Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Leo Cancer Care on the deal. Leo Cancer Care, an innovative start-up that is set to change the face of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Blend on the deal while Goodwin Procter represented the underwriters. Blend Labs, Inc. announced the pricing of its initial public...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati, P.C. acted as legal counsel to Aurora, while Skadden, Arps, Slate, Meagher & Flom LLP advised Reinvent. Sullivan & Cromwell LLP...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ascentage Pharma on the deal. Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ascentage Pharma on the deal. Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Entrata on the deal, while Simpson Thacher advised Silver Lake on the deal. Latham & Watkins LLP represented Dragoneer on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Grid Dynamics on the deal. Grid Dynamics Holdings, Inc. (NASDAQ:GDYN), a leader in enterprise-level digital transformation, announced the pricing of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Grid Dynamics on the deal, while Ortoli Rosenstadt LLP acted for selling shareholder GDD International Holding Company. Grid Dynamics Holdings,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Acumen Pharmaceuticals on the deal. Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS), a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target...
You must be a Standard 1 Year member to access this content.
